Frontiers in Microbiology (May 2019)

Alpha-Herpesvirus Thymidine Kinase Genes Mediate Viral Virulence and Are Potential Therapeutic Targets

  • Ying Xie,
  • Ying Xie,
  • Ying Xie,
  • Liping Wu,
  • Liping Wu,
  • Liping Wu,
  • Mingshu Wang,
  • Mingshu Wang,
  • Mingshu Wang,
  • Anchun Cheng,
  • Anchun Cheng,
  • Anchun Cheng,
  • Qiao Yang,
  • Qiao Yang,
  • Qiao Yang,
  • Ying Wu,
  • Ying Wu,
  • Ying Wu,
  • Renyong Jia,
  • Renyong Jia,
  • Renyong Jia,
  • Dekang Zhu,
  • Dekang Zhu,
  • XinXin Zhao,
  • XinXin Zhao,
  • XinXin Zhao,
  • Shun Chen,
  • Shun Chen,
  • Shun Chen,
  • Mafeng Liu,
  • Mafeng Liu,
  • Mafeng Liu,
  • Shaqiu Zhang,
  • Shaqiu Zhang,
  • Shaqiu Zhang,
  • Yin Wang,
  • Zhiwen Xu,
  • Zhengli Chen,
  • Ling Zhu,
  • Qihui Luo,
  • Yunya Liu,
  • Yunya Liu,
  • Yunya Liu,
  • Yanling Yu,
  • Yanling Yu,
  • Yanling Yu,
  • Ling Zhang,
  • Ling Zhang,
  • Ling Zhang,
  • Xiaoyue Chen,
  • Xiaoyue Chen

DOI
https://doi.org/10.3389/fmicb.2019.00941
Journal volume & issue
Vol. 10

Abstract

Read online

Alpha-herpesvirus thymidine kinase (TK) genes are virulence-related genes and are nonessential for viral replication; they are often preferred target genes for the construction of gene-deleted attenuated vaccines and genetically engineered vectors for inserting and expressing foreign genes. The enzymes encoded by TK genes are key kinases in the nucleoside salvage pathway and have significant substrate diversity, especially the herpes simplex virus 1 (HSV-1) TK enzyme, which phosphorylates four nucleosides and various nucleoside analogues. Hence, the HSV-1 TK gene is exploited for the treatment of viral infections, as a suicide gene in antitumor therapy, and even for the regulation of stem cell transplantation and treatment of parasitic infection. This review introduces the effects of α-herpesvirus TK genes on viral virulence and infection in the host and classifies and summarizes the current main application domains and potential uses of these genes. In particular, mechanisms of action, clinical limitations, and antiviral and antitumor therapy development strategies are discussed.

Keywords